Expert Witness Profile · Expert B400A
This expert is a clinical pharmacologist with more than 35 years in the pharmaceutical industry, including director-level and senior leadership roles at several global pharmaceutical companies, leading cross-functional development teams from IND through Phase I-III trials and NDA/BLA submissions for marketed oncology compounds.
Expertise spans pharmacokinetics and pharmacodynamics (PK/PD) modeling, pharmacometrics, population PK, physiologically based pharmacokinetic (PBPK) modeling, drug metabolism (DMPK), toxicology, translational medicine, and FDA regulatory strategy across oncology, cardiovascular, and respiratory therapeutics, including kinase inhibitors and antibody-drug conjugates.
Attorneys retain this expert for pharmaceutical patent matters turning on PK/PD and formulation science, product liability cases involving drug exposure and dosing, and regulatory standard-of-care disputes.
Credentials
Formal Education
- Ph.D. in Physiology and Pharmacology from the University of Strathclyde
- Postdoctoral fellowship in Pharmacology from the Medical University of South Carolina
- Postdoctoral fellowship in Tumor Biochemistry from the German Cancer Research Centre (DKFZ)
Why Attorneys Retain This Expert
Expert Qualifications
- More than 35 years in pharmaceutical research and development
- Director-level leadership of IND through Phase III programs and NDA/BLA submissions
- Development leadership on marketed oncology therapeutics
- Deep modeling practice across PK/PD, pharmacometrics, and PBPK